Ovarian Cancer Trial, Recruiting NCT07508306 Sponsor: Faculty of Medicine of Tunis Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT07508306
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have a suspected ovarian cancer diagnosis based on an MRI scan, with results showing a high suspicion of cancer (called O-RADS 4 or 5)
  • Your cancer appears to be at an early stage (Stage I or II), based on MRI and scan results
  • You are already scheduled to have surgery that includes full removal and examination of lymph nodes in the pelvis and the area around the main abdominal artery
  • You are willing and able to sign a consent form after being fully informed about the trial

Who may not be able to join:

  • Your scans show lymph nodes that look suspicious or enlarged (generally larger than 10mm in a specific measurement) before surgery
  • There is imaging or surgical evidence that the cancer has spread outside the pelvis, including to the lining of the abdomen
  • You have previously had surgery to remove or sample lymph nodes, or major surgery on the large blood vessels in your abdomen or pelvis
  • You have previously had radiotherapy to your pelvis or abdomen
  • You have a known allergy or bad reaction to a type of blue dye called patent blue dye

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: KHALED NEJI, Professor, Maternity and neonatology center of Tunis

Phone: +21699696332

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Faculty of Medicine of Tunis
Registry
ClinicalTrials.gov
Start date
15 April 2026
Est. completion
31 December 2027

Where this trial is recruiting

Tunisia

Primary endpoints

Technical feasibility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov